Psoriatic Disease Response Index - Western Pacific

Psoriatic disease is a chronic disease that affects the skin (psoriasis), joints (psoriatic arthritis), and sometimes other organs of the body. The Western Pacific Region (WPR), defined by the WHO, consists of approximately 1.9 billion people across 27 countries. Estimates of Psoriasis in the Asia-Pacific region range from 0.11% in east Asia to 1.58% in Australasia. Individuals living with psoriatic disease often experience significant economic and quality-of-life (QoL) burden throughout their lifetimes.

In 2016, the World Health Organization (WHO) published the Global Report on Psoriasis, intended to “empower policy-makers with practical solutions to improve the health care and social inclusion of people living with psoriasis in their populations.” Based on their recommendations, IFPA developed an index to measure health systems’ responses to psoriatic disease on an international scale in five countries. This index report for the Western Pacific Region has been developed to measure the progress of psoriatic disease care in the following five countries: Australia, China, Japan, the Philippines and Singapore.